Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Final results of the ReoPro readministration registry.
Dery JP, Braden GA, Lincoff AM, Kereiakes DJ, Browne K, Little T, George BS, Sane DC, Cines DB, Effron MB, Mascelli MA, Langrall MA, Damaraju L, Barnathan ES, Tcheng JE; ReoPro Readministration Registry Investigators. Dery JP, et al. Among authors: effron mb. Am J Cardiol. 2004 Apr 15;93(8):979-84. doi: 10.1016/j.amjcard.2003.12.051. Am J Cardiol. 2004. PMID: 15081439
Characteristics and Predictors of Apparent Treatment Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data.
Jafari E, Cooper-DeHoff RM, Effron MB, Hogan WR, McDonough CW. Jafari E, et al. Among authors: effron mb. medRxiv [Preprint]. 2023 May 1:2023.04.28.23289293. doi: 10.1101/2023.04.28.23289293. medRxiv. 2023. Update in: Am J Hypertens. 2024 Jan 1;37(1):60-68. doi: 10.1093/ajh/hpad084. PMID: 37205447 Free PMC article. Updated. Preprint.
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.
Brener SJ, Barr LA, Burchenal JE, Katz S, George BS, Jones AA, Cohen ED, Gainey PC, White HJ, Cheek HB, Moses JW, Moliterno DJ, Effron MB, Topol EJ. Brener SJ, et al. Among authors: effron mb. Circulation. 1998 Aug 25;98(8):734-41. doi: 10.1161/01.cir.98.8.734. Circulation. 1998. PMID: 9727542 Clinical Trial.
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing.
Lincoff AM, LeNarz LA, Despotis GJ, Smith PK, Booth JE, Raymond RE, Sapp SK, Cabot CF, Tcheng JE, Califf RM, Effron MB, Topol EJ. Lincoff AM, et al. Among authors: effron mb. Ann Thorac Surg. 2000 Aug;70(2):516-26. doi: 10.1016/s0003-4975(00)01343-6. Ann Thorac Surg. 2000. PMID: 10969673
Abciximab readministration: results of the ReoPro Readministration Registry.
Tcheng JE, Kereiakes DJ, Lincoff AM, George BS, Kleiman NS, Sane DC, Cines DB, Jordan RE, Mascelli MA, Langrall MA, Damaraju L, Schantz A, Effron MB, Braden GA. Tcheng JE, et al. Among authors: effron mb. Circulation. 2001 Aug 21;104(8):870-5. doi: 10.1161/hc3301.094533. Circulation. 2001. PMID: 11514371 Clinical Trial.
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE, Kandzari DE, Grines CL, Cox DA, Effron MB, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Mehran R, Stone GW; CADILLAC Investigators. Tcheng JE, et al. Among authors: effron mb. Circulation. 2003 Sep 16;108(11):1316-23. doi: 10.1161/01.CIR.0000087601.45803.86. Epub 2003 Aug 25. Circulation. 2003. PMID: 12939213 Clinical Trial.
117 results